Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Terminated 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 4Vomiting 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Prostatic Neoplasms 1Postoperative Nausea and Vomiting 1Pain, Intractable 1Oropharyngeal Neoplasms 1Nausea 1Lymphoma, Non-Hodgkin 1Leukemia, Plasma Cell 1Immunoglobulin Light-chain Amyloidosis 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Cancer Pain 1Breast Neoplasms 1

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × Calcium Dobesilate × Clear all
NCT02234466 2014-09-09

Preoperative Oral Dexamethasone to Improve Recovery After Surgery

University of Manitoba

Phase 2 Unknown
80 enrolled
Breast

Breast Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡